FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 12 filers reported holding FENNEC PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $4,000 | -84.0% | 642 | -81.1% | 0.00% | – |
| Q4 2020 | $25,000 | +257.1% | 3,395 | +237.1% | 0.00% | – |
| Q3 2020 | $7,000 | -50.0% | 1,007 | -42.6% | 0.00% | – |
| Q2 2020 | $14,000 | – | 1,755 | +9650.0% | 0.00% | – |
| Q1 2020 | $0 | – | 18 | 0.0% | 0.00% | – |
| Q4 2019 | $0 | – | 18 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | – | 18 | -81.4% | 0.00% | – |
| Q2 2019 | $0 | – | 97 | +223.3% | 0.00% | – |
| Q1 2019 | $0 | -100.0% | 30 | -83.7% | 0.00% | – |
| Q4 2018 | $1,000 | 0.0% | 184 | +87.8% | 0.00% | – |
| Q3 2018 | $1,000 | 0.0% | 98 | -1.0% | 0.00% | – |
| Q2 2018 | $1,000 | – | 99 | +450.0% | 0.00% | – |
| Q1 2018 | $0 | – | 18 | 0.0% | 0.00% | – |
| Q4 2017 | $0 | – | 18 | 0.0% | 0.00% | – |
| Q3 2017 | $0 | – | 18 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Solas Capital Management, LLC | 849,979 | $3,400,000 | 3.47% |
| Southpoint Capital Advisors LP | 3,997,214 | $15,989,000 | 0.60% |
| Opaleye Management Inc. | 295,000 | $1,180,000 | 0.36% |
| 683 Capital Management, LLC | 971,351 | $3,885,000 | 0.35% |
| Avoro Capital Advisors LLC | 1,105,999 | $4,424,000 | 0.15% |
| Eventide Asset Management | 720,000 | $2,880,000 | 0.09% |
| Granahan Investment Management | 439,083 | $1,756,000 | 0.09% |
| Hartford Financial Management Inc. | 20,300 | $81,000 | 0.03% |
| OXFORD ASSET MANAGEMENT LLP | 75,236 | $301,000 | 0.01% |
| Paloma Partners Management Co | 54,400 | $218,000 | 0.00% |